Ipamorelin

Also known as: NNC 26-0161

Growth Hormone

Phase II

Ipamorelin is a highly selective growth hormone secretagogue peptide that stimulates GH release without significantly affecting cortisol, ACTH, prolactin, or aldosterone levels. It is considered one of the cleanest GH-releasing peptides due to its selectivity.

Regulatory & Approval Status

Not FDA Approved

Ipamorelin is an investigational growth hormone secretagogue that has reached Phase 2 clinical testing but is not approved by the FDA for human use.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.